2025-04-01
Comparison of chemoport and Hickman central venous catheters in patients with hematological cancer
2025-04-01 • Changsung Han, Gwon-Min Kim, Ho Jin Shin, Do Young Kim, Chung Won Lee, Miju Bae, Jong‐Won Kim, Jong‐Hwan Park, Jonggeun Lee, Up Huh
For immunocompromised patients with hematological malignancies, chemoport usage may reduce the occurrence of infections, ensuring the long-term maintenance of vascular access. Furthermore, the average reinsertion rate of both groups was confirmed to be more than 1. Therefore, performing the stem cell transplantation procedure using Hickman CVC and then changing to chemoport for subsequent chemotherapy can minimize the infection risk and safely preserve long-term vascular access. Additionally, the overall complicat…